Compositions comprising benzo (G) quinoline derivatives and prostaglandin derivatives

Details for Australian Patent Application No. 2004269910 (hide)

Owner Novartis AG

Inventors Lambrou, George N.; Reinhart, Thomas; Latour, Elisabeth Jeanne

Agent Davies Collison Cave

Pub. Number AU-A-2004269910

PCT Pub. Number WO2005/023258

Priority 0320869.1 05.09.03 GB; 0323828.4 10.10.03 GB

Filing date 3 September 2004

Wipo publication date 17 March 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/5575 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023258 Priority application(s): WO2005/023258

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269920-Novel targets for the treatment of retina diseases

2004269903-The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma